News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,909 Results
Type
Article (65118)
Company Profile (433)
Press Release (685358)
Section
Business (209129)
Career Advice (3632)
Deals (35847)
Drug Delivery (121)
Drug Development (86385)
Employer Resources (183)
FDA (17076)
Job Trends (15858)
News (358910)
Policy (35504)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (9)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (7)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2952)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (83)
Alliances (52572)
ALS (84)
Alzheimer's disease (1437)
Antibody-drug conjugate (ADC) (127)
Approvals (17029)
Artificial intelligence (255)
Autoimmune disease (13)
Automation (14)
Bankruptcy (334)
Best Places to Work (12387)
BIOSECURE Act (21)
Biosimilars (100)
Biotechnology (324)
Bladder cancer (57)
Brain cancer (27)
Breast cancer (249)
Cancer (1925)
Cardiovascular disease (153)
Career advice (3073)
Career pathing (32)
CAR-T (150)
Cell therapy (427)
Cervical cancer (15)
Clinical research (69195)
Collaboration (756)
Compensation (392)
Complete response letters (28)
COVID-19 (2816)
CRISPR (38)
C-suite (193)
Cystic fibrosis (104)
Data (1757)
Decentralized trials (2)
Denatured (39)
Depression (46)
Diabetes (243)
Diagnostics (6715)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (119)
Drug pricing (116)
Drug shortages (32)
Duchenne muscular dystrophy (70)
Earnings (84969)
Editorial (34)
Employer branding (23)
Employer resources (160)
Events (120814)
Executive appointments (608)
FDA (18088)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (669)
Gene editing (98)
Generative AI (30)
Gene therapy (300)
GLP-1 (775)
Government (4996)
Grass and pollen (4)
Guidances (46)
Healthcare (20447)
Huntington's disease (23)
IgA nephropathy (23)
Immunology and inflammation (107)
Indications (24)
Infectious disease (2944)
Inflammatory bowel disease (139)
Inflation Reduction Act (11)
Influenza (45)
Intellectual property (74)
Interviews (702)
IPO (16903)
IRA (51)
Job creations (3958)
Job search strategy (2511)
Kidney cancer (10)
Labor market (25)
Layoffs (505)
Leadership (19)
Legal (8458)
Liver cancer (73)
Lung cancer (281)
Lymphoma (124)
Machine learning (2)
Management (63)
Manufacturing (273)
MASH (62)
Medical device (14096)
Medtech (14101)
Mergers & acquisitions (19396)
Metabolic disorders (656)
Multiple sclerosis (64)
NASH (23)
Neurodegenerative disease (86)
Neuropsychiatric disorders (29)
Neuroscience (1916)
NextGen: Class of 2025 (7366)
Non-profit (5000)
Northern California (2257)
Now hiring (31)
Obesity (361)
Opinion (263)
Ovarian cancer (64)
Pain (80)
Pancreatic cancer (72)
Parkinson's disease (125)
Partnered (18)
Patents (193)
Patient recruitment (83)
Peanut (50)
People (58269)
Pharmaceutical (87)
Pharmacy benefit managers (21)
Phase I (21421)
Phase II (30275)
Phase III (22897)
Pipeline (841)
Podcasts (112)
Policy (125)
Postmarket research (2992)
Preclinical (9347)
Press Release (72)
Prostate cancer (89)
Psychedelics (38)
Radiopharmaceuticals (265)
Rare diseases (376)
Real estate (6213)
Recruiting (72)
Regulatory (24029)
Reports (39)
Research institute (2619)
Resumes & cover letters (586)
Rett syndrome (2)
RNA editing (1)
RSV (42)
Schizophrenia (69)
Series A (122)
Series B (72)
Service/supplier (12)
Sickle cell disease (55)
Southern California (1946)
Special edition (17)
Sponsored (33)
Startups (3734)
State (2)
Stomach cancer (14)
Supply chain (60)
The Weekly (72)
United States (20331)
Vaccines (717)
Venture capitalists (34)
Webinars (13)
Weight loss (270)
Women's health (34)
Worklife (16)
Date
Today (181)
Last 7 days (814)
Last 30 days (3172)
Last 365 days (36317)
2025 (6126)
2024 (37278)
2023 (42143)
2022 (53454)
2021 (58219)
2020 (57009)
2019 (50480)
2018 (38289)
2017 (35334)
2016 (35522)
2015 (41068)
2014 (34540)
2013 (29996)
2012 (31608)
2011 (31766)
2010 (30175)
Location
Africa (1066)
Alabama (53)
Alaska (7)
Arizona (203)
Arkansas (13)
Asia (44131)
Australia (7641)
California (5199)
Canada (1790)
China (442)
Colorado (236)
Connecticut (258)
Delaware (116)
Europe (101301)
Florida (758)
Georgia (182)
Idaho (61)
Illinois (526)
India (22)
Indiana (279)
Iowa (8)
Japan (130)
Kansas (99)
Kentucky (26)
Louisiana (8)
Maine (65)
Maryland (811)
Massachusetts (4078)
Michigan (218)
Minnesota (363)
Mississippi (2)
Missouri (74)
Montana (30)
Nebraska (25)
Nevada (53)
New Hampshire (66)
New Jersey (1486)
New Mexico (30)
New York (1489)
North Carolina (985)
North Dakota (8)
Northern California (2257)
Ohio (186)
Oklahoma (13)
Oregon (34)
Pennsylvania (1159)
Puerto Rico (7)
Rhode Island (24)
South America (1431)
South Carolina (14)
South Dakota (1)
Southern California (1946)
Tennessee (86)
Texas (756)
Utah (154)
Virginia (122)
Washington D.C. (58)
Washington State (508)
West Virginia (3)
Wisconsin (50)
750,909 Results for "the international society on thrombosis and haemostasis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress
BioMarin Pharmaceutical Inc. will be presented at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Bangkok, Thailand, June 22-26, 2024.
June 7, 2024
·
15 min read
Biotech Beach
Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and Haemostasis
Poseida Therapeutics, Inc. today announced that two abstracts have been accepted for presentation at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), being held in Montreal, Canada and virtually on June 24-28, 2023.
May 22, 2023
·
4 min read
Drug Development
Hemab Therapeutics to Present New Preclinical Data on HMB-001 in Factor VII Deficiency and Initial Findings from Glanzmann Thrombasthenia Natural History Study at the International Society on Thrombosis and Haemostasis (ISTH) 2023 Congress
Hemab Therapeutics announced it will present data from preclinical research of HMB-001 in Factor VII deficiency at the upcoming International Society on Thrombosis and Haemostasis 2023 Congress, June 24 – 28, in Montreal.
June 15, 2023
·
4 min read
Drug Development
Rallybio Announces Acceptance of Abstract for RLYB212 at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Rallybio Corporation announced that an abstract for RLYB212 reporting results from the Phase 1b proof-of-concept study has been accepted for presentation at the 31st Congress of the International Society on Thrombosis and Haemostasis, which will take place in Montreal from June 24-28.
April 3, 2023
·
3 min read
ISTH 2024 Unveils Late-Breakthrough Abstracts to be Presented in Bangkok, Thailand Showcasing Groundbreaking Science and Research
The International Society on Thrombosis and Haemostasis announces that all ISTH 2024 Congress abstracts are available online, including late-breakthrough abstracts, to give a detailed glimpse into the posters, presentations and plenaries that will be presented at the Congress in Bangkok, Thailand.
June 17, 2024
·
4 min read
Drug Development
Rallybio to Present Data from the RLYB212 Phase 1b Proof-of-Concept Study at the 31st Congress of the International Society on Thrombosis and Haemostasis
Rallybio Corporation (Nasdaq: RLYB) today announced that results from the RLYB212 Phase 1b proof-of-concept study will be presented at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), which will take place in Montreal from June 24-28.
June 9, 2023
·
5 min read
Press Releases
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women’s Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)
February 27, 2025
·
4 min read
Octapharma’s continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024
The most recent developments from Octapharma’s Haematology portfolio will be presented at the 32nd Congress of the International Society on Thrombosis and Haemostasis on June 22–26, 2024, in Bangkok, Thailand.
June 10, 2024
·
9 min read
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024
TiumBio Co., Ltd. announced today that the company presented clinical outcomes of its hemophilia treatment, TU7710, at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) and embarked on building new global partnerships.
June 24, 2024
·
3 min read
New NETs Data Presented at International Society on Thrombosis and Haemostasis (ISTH) Congress
VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), in collaboration with researchers at the University of Namur and QUALIblood in Belgium has published a poster presentation entitled “Evaluation and comparison of NETosis biomarkers in sepsis and COVID-19 patients” at the International Society on Thrombosis and Haemostasis (ISTH) Congress earlier this week.
July 13, 2022
·
5 min read
1 of 75,091
Next
